Hostname: page-component-cd9895bd7-gbm5v Total loading time: 0 Render date: 2024-12-26T13:12:32.400Z Has data issue: false hasContentIssue false

Preparedness for Candida auris in Canadian Nosocomial Infection Surveillance Program (CNISP) hospitals, 2018

Published online by Cambridge University Press:  13 January 2020

Felipe Garcia-Jeldes
Affiliation:
CHU de Québec, Université Laval, Québec, Québec, Canada
Robyn Mitchell
Affiliation:
Public Health Agency of Canada, Ottawa, Ontario, Canada
Amrita Bharat
Affiliation:
National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada
Allison McGeer*
Affiliation:
Sinai Health System, Toronto, Ontario, Canada Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
*
Author for correspondence: Allison McGeer, E-mail: [email protected]

Abstract

We surveyed Canadian Nosocomial Infection Surveillance Program hospitals to evaluate infection prevention and microbiology laboratory preparedness for Candida auris. We identified significant gaps: most hospitals were not prepared to screen patients for colonization, and only one-half of laboratories reported identifying all clinically significant Candida isolates to the species level.

Type
Concise Communication
Copyright
© 2020 by The Society for Healthcare Epidemiology of America. All rights reserved.

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

PREVIOUS PRESENTATION: This work was presented in part as poster no. 2166 at IDWeek 2018 on October 6, 2018, in Los Angeles, California.

a

Other members of the CNISP C. auris interest group: Ghada Al-Rawahi, British Columbia Children’s Hospital, BC Women’s Hospital, Vancouver, BC; Elizabeth Brodkin, Fraser Health Authority, Vancouver, BC, Marthe Charles and Titus Wong, Vancouver General Hospital, Vancouver, BC; Jeannette Comeau, IWK Health Centre, Halifax, NS; Ian Davis, QEII Health Sciences Centre, Halifax, NS; Johan Delport, London Health Sciences Centre, London, ON; Tanis Dingle, Alberta Public Laboratories, Edmonton, AB; Philippe Dufresne, Laboratoire de Santé Publique du Québec, Sainte-Anne-de-Bellevue, QC; Chelsey Ellis, The Moncton Hospital, Moncton, NB; Joanne Embree, Health Sciences Centre, Winnipeg, MB; Charles Frenette, McGill University Health Centre, Montreal, QC; George Golding and Michael Mulvey, National Microbiology Laboratory, Winnipeg, MB; Linda Hoang, British Columbia Centre for Disease Control Public Health Laboratory, Vancouver, BC; Susy Hota, University Health Network, Toronto, ON; Kevin C. Katz, North York General Hospital, Toronto, ON; Pamela Kibsey, Royal Jubilee Hospital, Victoria, BC; Julianne V. Kus, Public Health Ontario, Toronto, ON; Bonita E. Lee, Stollery Children’s Hospital, Edmonton, AB; Marie-Astrid Lefebvre, Montreal Children’s Hospital, Montreal, QC; Yves Longtin and Maxime-Antoine Tremblay, SMBD-Jewish General Hospital, Montreal, QC; Kathy Malejczyk, Regina Qu’Appelle Health Region, Regina, SK; Shazia Masud and Dale Purych, Surrey Memorial Hospital, Surrey, BC; Dominik Mertz and Deborah Yamamura, McMaster University and Hamilton Health Sciences, Hamilton, ON; Rajni Pantelidis and David Richardson, William Osler Health System, Brampton, ON; Ilan Schwartz, University of Alberta, Edmonton, AB; and Stephanie Smith, University of Alberta Hospital, Edmonton, AB.

References

National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Foodborne, Waterborne, and Environmental Diseases (DFWED). Candida auris. Centers for Disease Control and Prevention website. https://www.cdc.gov/fungal/candida-auris/index.html Accessed June 28, 2019.Google Scholar
Candida auris in healthcare settings—Europe. European Centre for Disease Prevention and Control website. https://ecdc.europa.eu/sites/portal/files/documents/RRA-Candida-auris-European-Union-countries.pdf. Updated April 23, 2018. Accessed June 28, 2019.Google Scholar
Chow, NA, Gade, L, Tsay, SV, et al. US Candida auris Investigation Team. Multiple introductions and subsequent transmission of multidrug-resistant Candida auris in the USA: a molecular epidemiological survey. Lancet Infect Dis 2018:13771384.Google Scholar
Ruiz-Gaitán, A, Moret, AM, Tasias-Pitarch, M, et al.An outbreak due to Candida auris with prolonged colonisation and candidaemia in a tertiary care European hospital. Mycoses 2018;61:498505.CrossRefGoogle Scholar
Ontario Agency for Health Protection and Promotion (Public Health Ontario), Provincial Infectious Diseases Advisory Committee. Interim guide for infection prevention and control of Candida auris. Public Health Ontario website. www.publichealthontario.ca/en/eRepository/pidac-ipac-candida-auris.pdf. Accessed June 28, 2019.Google Scholar
Schwartz, IS, Hammond, GW.First reported case of multidrug-resistant Candida auris in Canada. Can Commun Dis Rep 2017;43:150153.CrossRefGoogle ScholarPubMed
Bharat, A, Alexander, DC, Dingle, TC, et al.Candida auris cases in Canada, 2012–2018. In: Program and Abstracts of the 2019 AMMI Canada-CACMID Annual Conference. Abstract #P81. Ottawa, Ontario; April 3–6, 2019. doi: 10.3138/jammi_4.s1.abst-02.Google Scholar
Mataseje, LF, Abdesselam, K, Vachon, J, et al.Results from the Canadian Nosocomial Infection Surveillance Program on Carbapenemase-Producing Enterobacteriaceae, 2010 to 2014. Antimicrob Agents Chemother 2016;60:67876794.CrossRefGoogle ScholarPubMed
Hamprecht, A, Barber, AE, Mellinghoff, SC, et al.German Candida auris Study Group. Candida auris in Germany and previous exposure to foreign healthcare. Emerg Infect Dis 2019;25:17631765.CrossRefGoogle Scholar
Karmarkar, E, O’Donnell, K, Prestel, C.et al. Regional assessment and containment of Candida auris transmission in post-acute care settings—Orange County, California, 2019. In: Program and abstracts of IDWeek2019. Abstract #LB1. Washington, DC; October 2–6, 2019.CrossRefGoogle Scholar
Eckbo, EJ, Tang, V, Roscoe, D, et al.Assessment of identification methods for Candida auris in microbiology laboratories in British Columbia. J Asso Med Microbiol Infect Dis Can 2018;3(51). Abstract SP24. doi: 10.3138/jammi.3.suppl.01.Google Scholar
Supplementary material: File

Garcia-Jeldes et al. supplementary material

Garcia-Jeldes et al. supplementary material

Download Garcia-Jeldes et al. supplementary material(File)
File 40.8 KB